• Home
  • About Us

Idiopathic Pulmonary Fibrosis

Jeremy Feldman, MD

  • What is Idiopathic Pulmonary Fibrosis?
    • Idiopathic Pulmonary Fibrosis Definition
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy and Prognosis for Idiopathic Pulmonary Fibrosis
  • Diagnosing & Monitoring PF
    • Monitoring Progress of IPF
    • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis
  • PF Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
      • Update on Oxygen Use
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation
  • PF Advocacy & News
  • FAQ’s
    • Respiratory failure, NSIP, diet
    • Leg swelling, lung biopsy, side effects & pets
    • FAQ’s Enzyme Therapy, Progression of IPF & Oxygen
    • FAQ: Diarrhea, Fibrosis Reversal, IPF Symptoms
    • FAQ: Oxygen Flow, Anesthesia & Genetics
    • FAQ: Contagious Cough? Stem Cells, Familial IPF, Flying
    • FAQ: GERD, Fatigue & Environmental Exposure
    • FAQ: How to Travel to Your Doctor’s Office with Oxygen
    • FAQ: Lung Biopsy with Pulmonary Fibrosis
    • FAQ’s: Alcohol, Clinical Trials, Pulmonary Function Testing
    • FAQs: Emphysema, Exercise & Lung Biopsy

End of Life Planning for IPF Patients

July 9, 2015 By Dr. Jeremy Feldman

IPF life expectancy

Caring for patients with Pulmonary Fibrosis requires not just caring for their lung disease but also the impact that their lung disease has on them overall.  With the approval of Esbreit (pirfenidone) and OFEV (nintedanib), we finally have medicines that slow the progression of IPF.  However, these drugs are not a cure.  Despite our best efforts, most patients with IPF will still die from their lung disease.  We are very optimistic that over the next few years we will have more effective medicines to offer our IPF patients.  However, today, caring for IPF patients still means that we have to confront the reality that much as we plan for our patients to live with IPF we need to prepare them to die from IPF.  This does not mean that we should dwell on end of life matters.  It does mean that part of the discussion around IPF and disease progression must involve end of life planning.

I encourage my patients to consider end of life planning early in their disease course so that once they have addressed the important issues they don’t need to focus on those issues.  Some patients are reluctant to consider end of life planning as they feel that it represents acceptance of their disease process progressing or they are afraid to discuss matters with their family.  Your physician should be comfortable helping initiate the discussion.  Key steps in end of life planning are as follows:

1.      Every adult IPF patient should have an advanced directive.

This is a straightforward form that may be downloaded from the Internet.  It expresses your wishes with regards to the types of interventions you would and would not like if you become critically ill.  If you do not have an advanced directive, then your doctors will provide maximum support and life-sustaining measures until told to stop by your power of attorney (see below) or until your health care team reaches a point of futility.  The major areas of an advanced directive are listed below.

a.     Life support:  Would you want to be maintained on a mechanical ventilator?

b.     CPR:  Would you want your healthcare team to do chest compression and shock your heart if it stops?

c.     Artificial nutrition:  Would you want to be sustained with a feeding tube in your stomach?

2.     Power of Attorney for health care

This is a legal document that assigns a surrogate decision maker or decision makers if you are unable to make decisions about your healthcare.

Think carefully and chose someone who will be able to make decisions the way you would want them to.  Some family members may not be able to carry through with a plan to limit interventions at the end of life even if you had so advised them.  Most commonly power of attorney is your spouse, parent or grown children.  However, it may be any other adult that you chose.  If you do not have a power of attorney for healthcare, then each state has formal laws that designate a surrogate.  Most states recognize your spouse first then your adult children and then your parents in descending order of priority.

3.     A Will or Trust is a legal document that specifies what happens to your possessions and assets.

Every adult should have a basic will.  A trust is often a more complex document that is very useful if you have substantial assets or a complex family structure.

Planning ahead does not signify that you are ready to die or that you are somehow pulling back from an aggressive treatment course.  Leaving end of life decisions until you are very sick places additional burden on you and your family when you are less well equipped to deal with them.

Filed Under: IPF Healthcare

Featured Blog Posts

PF vs IPF

Non-Idiopathic Pulmonary Fibrosis

Foods not tolerated well in GERD

Pulmonary Fibrosis and Weight Loss

Diagnosing IPF

Pulmonary Fibrosis That is Not Idiopathic

Recent Posts

  • Interstitial Lung Disease and Progressive Pulmonary Fibrosis
  • Pamrevlumab Ineffective in Treating IPF
  • New Drugs Moving Forward for IPF

Search by Keyword (Examples: GERD, Coughing, Traveling, etc.)

Search by Category

Popular Articles

IPF patient with doctor

Idiopathic Pulmonary Fibrosis Treatment Options

What is IPF?

  • What is Idiopathic Pulmonary Fibrosis?
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and IPF
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy & Prognosis for Pulmonary Fibrosis

Diagnosing IPF

  • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis

Treating IPF

  • Pulmonary Fibrosis Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation

Disclaimer